Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation

Immunology Letters

Volumn 90, Issue 2-3, 2003, Pages 67-70

  Locher, Christopher P ^a,c   Putnam, David ^b,d   Langer, Robert ^b   Witt, Stephanie A ^a   Ashlock, Brittany M ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c MAXYGEN INC   (United States)

^d Cornell University   (United States)

Author keywords

Adjuvant; AIDS; Animal model; Antibodies; Gene therapy

Indexed keywords

DNA VACCINE; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; IMIDAZOLE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; NAKED DNA; NANOPARTICLE; POLYCATION; RECOMBINANT DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SYNTHESIS; ENDOSOME; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; MOUSE STRAIN; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; VIRUS ENVELOPE;

EID: 0346365484     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2003.02.001     Document Type: Article

References (14)

1. Ulmer J.B., Sadoff J.C., Liu M.A. Curr. Opin. Immunol. 8(4):1996;531-536.
2. Robinson H.L. Nat. Immunol. 2(4):2002;239-250.
3. Hasan U.A., Abai A.M., Harper D.R., Wren B.W., Morrow W.J.W. J. Immunol. Methods. 229(1):1999;1-22.
4. Pouton C.W., Seymour L.W. Adv. Drug Deliv. Rev. 46:2001;187-203.
5. Singh M., Briones M., Ott G., O'Hagan D. Proc. Natl. Acad. Sci. U.S.A. 97(2):2000;811-816.
6. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A.N., Davis S.S. Adv. Drug Deliv. Rev. 51(1-3):2001;81-96.
7. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., Zhang Z.Q., Simon A.J., Trigona W.L., Dubey S.A., Huang L., Harris V.A., Long R.S., Liang X., Handt L., Schleif W.A., Zhu L., Freed D.C., Persaud N.V., Guan L., Punt K.S., Tang A., Chen M., Wilson K.A., Collins K.B., Heidecker G.J., Fernandez V.R., Perry H.C., Joyce J.G., Grimm K.M., Cook J.C., Keller P.M., Kresock D.S., Mach H., Troutman R.D., Isopi L.A., Williams D.M., Xu Z., Bohannon K.E., Volkin D.B., Montefiori D.C., Miura A., Krivulka G.R., Lifton M.A., Kuroda M.J., Schmitz J.E., Letvin N.L., Caulfield M.J., Bett A.J., Youil R., Kaslow D.C., Emini E.A. Nature. 415(6869):2002;331-335.
8. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., Felgner P.L. J. Biol. Chem. 269(4):1994;2550-2561.
9. Gregoriadis G., McCormack B., Obrenovic M., Saffie R., Zadi B., Perrie Y. Methods. 19(1):1999;156-162.
10. Putnam D., Gentry C.A., Pack D.W., Langer R. Proc. Natl. Acad. Sci. U.S.A. 98(3):2001;1200-1205.
11. Barnett S.W., Legg H.S., Sun Y., Klinger J., Blackbourn D.J., Locher C.P., Levy J.A. Virology. 222(1):1996;257-261.
12. Locher C.P., Witt S.A., Herndier B.G., Tenner-Racz K., Racz P., Levy J.A. Immunol. Rev. 183:2001;127-140.
13. Mattner F., Fleitmann J.K., Lingnau K., Schmidt W., Egyed A., Fritz J., Zauner W., Wittmann B., Gorny I., Berger M., Kirlappos H., Otava A., Birnstiel M.L., Buschle M. Cancer Res. 62(5):2002;1477-1480.
14. Singh M., Briones M., Ott G., O'Hagan D. Proc. Natl. Acad. Sci. U.S.A. 97(2):2000;811-816.